Literature DB >> 20629033

Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007.

Liliane Chatenoud1, Paola Bertuccio, Cristina Bosetti, Fabio Levi, Eva Negri, Carlo La Vecchia.   

Abstract

BACKGROUND: Over the last 4 decades, childhood cancer mortality declined in most developed areas of the world. However, scant information is available from middle-income and developing countries. The authors analyzed and compared patterns in childhood cancer mortality in 24 developed and middle-income countries in America, Asia, and Oceania between 1970 and 2007.
METHODS: Childhood age-standardized annual mortality rates were derived from the World Health Organization (WHO) database for all neoplasms, bone and kidney cancer, non-Hodgkin lymphoma (NHL), and leukemias.
RESULTS: Since 1970, rates for all childhood cancers dropped from approximately 8 per 100,000 boys to 3 per 100,000 boys and from 6 per 100,000 girls to 2 per 100,000 girls in North America and Japan. Latin American countries registered rates of approximately 5 per 100,000 boys and 4 per 100,000 girls for 2005 through 2007, similar to the rates registered in more developed areas in the early 1980s. Similar patterns were observed for leukemias, for which the mortality rates were 0.81 per 100,000 boys and 0.55 per 100,000 girls in North America, 0.86 per 100,000 boys and 0.68 per 100,000 girls in Japan, and 1.98 per 100,000 boys and 1.65 per 100,000 girls in Latin America for 2005 through 2007. Bone cancer rates for 2005 through 2007 were approximately 2-fold higher in Argentina than in the United States. During the same period, Mexico registered the highest rate for kidney cancer and Colombia registered the highest rate for NHL, whereas the lowest rates were registered by Japan for kidney and by Japan and the United States for NHL.
CONCLUSIONS: Improvements in the adoption of current integrated treatment protocols in Latin American and other lower- and middle-income countries worldwide would avoid a substantial proportion of childhood cancer deaths.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20629033     DOI: 10.1002/cncr.25406

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.

Authors:  Paola Friedrich; Roberta Ortiz; Kelly Strait; Soad Fuentes; Yéssica Gamboa; Ingrid Arambú; María Ah-Chu-Sanchez; Wendy London; Carlos Rodríguez-Galindo; Federico Antillón-Klussmann; Fulgencio Báez
Journal:  Cancer       Date:  2012-09-12       Impact factor: 6.860

2.  Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculation.

Authors:  Na Wang; Liang Huang; Di Wang; Jin Wang; Lijun Jiang; Kuangguo Zhou; Yunfan Yang; Danmei Xu; Jianfeng Zhou
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

3.  Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Didier Ismael May-Hau; Diego Alberto Bárcenas-López; Juan Carlos Núñez-Enríquez; Vilma Carolina Bekker-Méndez; Fredy Omar Beltrán-Anaya; Elva Jiménez-Hernández; Mónica Patricia Ortíz-Maganda; Francisco Xavier Guerra-Castillo; Aurora Medina-Sanson; Janet Flores-Lujano; Jorge Alfonso Martín-Trejo; José Gabriel Peñaloza-González; Martha Margarita Velázquez-Aviña; José Refugio Torres-Nava; Gabriela Alicia Hernández-Echáurregui; Rosa Martha Espinosa-Elizondo; María de Lourdes Gutiérrez-Rivera; Rodrigo Sanchez-Hernandez; María Luisa Pérez-Saldívar; Luz Victoria Flores-Villegas; Laura Elizabeth Merino-Pasaye; David Aldebarán Duarte-Rodríguez; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Haydeé Rosas-Vargas; Alfredo Hidalgo-Miranda; Juan Manuel Mejía-Aranguré; Silvia Jiménez-Morales
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

4.  Cancer Progress and Priorities: Childhood Cancer.

Authors:  Philip J Lupo; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06       Impact factor: 4.090

5.  Childhood cancer mortality in Japan, 1980-2013.

Authors:  Limin Yang; Junichiro Fujimoto
Journal:  BMC Cancer       Date:  2015-06-01       Impact factor: 4.430

6.  Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program.

Authors:  Roberto Rivera-Luna; Jaime Shalkow-Klincovstein; Liliana Velasco-Hidalgo; Rocio Cárdenas-Cardós; Marta Zapata-Tarrés; Alberto Olaya-Vargas; Marco R Aguilar-Ortiz; Eduardo Altamirano-Alvarez; Cecilia Correa-Gonzalez; Fernando Sánchez-Zubieta; Francisco Pantoja-Guillen
Journal:  BMC Cancer       Date:  2014-10-29       Impact factor: 4.430

Review 7.  Whole-body MRI in pediatric patients with cancer.

Authors:  Marcos Duarte Guimarães; Julia Noschang; Sara Reis Teixeira; Marcel Koenigkam Santos; Henrique Manoel Lederman; Vivian Tostes; Vikas Kundra; Alex Dias Oliveira; Bruno Hochhegger; Edson Marchiori
Journal:  Cancer Imaging       Date:  2017-02-10       Impact factor: 3.909

8.  Childhood cancer mortality trends in Brazil, 1979-2008.

Authors:  Sima Ferman; Marceli de Oliveira Santos; Juliana Moreira de Oliveira Ferreira; Rejane de Souza Reis; Julio Fernando Pinto Oliveira; Maria S Pombo-de-Oliveira; Beatriz de Camargo
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

9.  Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico.

Authors:  Ricardo Pérez-Cuevas; Svetlana V Doubova; Marta Zapata-Tarres; Sergio Flores-Hernández; Lindsay Frazier; Carlos Rodríguez-Galindo; Gabriel Cortes-Gallo; Salomon Chertorivski-Woldenberg; Onofre Muñoz-Hernández
Journal:  Pediatr Blood Cancer       Date:  2012-08-08       Impact factor: 3.167

10.  Years of Life Lost and Childhood and Adolescent Cancer Mortality in Yazd Province, Iran (2004-2009).

Authors:  M Mirzadeh; M Mirzaei; M Mirzaei; H ShogaeiFar
Journal:  Iran J Ped Hematol Oncol       Date:  2015-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.